Autologous Bone Marrow Mesenchymal Stem Cells Associated with Tantalum Rod Implantation and Vascularized Iliac Grafting for the Treatment of End-Stage Osteonecrosis of the Femoral Head

<div>A 40-year-old male patient with ARCO stage IV ONFH at right received the treatment of BMSCs associating with porous tantalum rod implantation combined with vascularized iliac grafting. Radiographs were taken before operation (a), 18 months after operation (b), and 54 months after operation (c). (c) The femoral head remained circular, but collapse was found again in the femoral head.</div>

BioMed Research International

fig6

Figure 6

Figure 6: Autologous Bone Marrow Mesenchymal Stem Cells Associated with Tantalum Rod Implantation and Vascularized Iliac Grafting for the Treatment of End-Stage Osteonecrosis of the Femoral Head 

Figure 6 | Autologous Bone Marrow Mesenchymal Stem Cells Associated with Tantalum Rod Implantation and Vascularized Iliac Grafting for the Treatment of End-Stage Osteonecrosis of the Femoral Head 